Amyloidosis is associated with cerebralamyloid angiopathy, bloodcoagulation disruption, fibrinolytic disturbance,8,9 FXIIKallikrein/Kinin activation, and thromboinflammation,10 suggesting potential links between S-protein amyloidogenesisand COVID-19 phenotypes. Here, PROS1 is linked to COVID-19.